- Home
- / Bellus Health
Bellus Health
Revenue
$16 K
FY, 2022
Bellus Health Summary
Company Summary
- Overview
- Bellus Health is a biopharmaceutical development company advancing therapeutics for conditions with high unmet medical needs. It is engaged in the development of a drug candidate for the treatment of chronic cough and chronic pruritus, or chronic itch.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2010
- HQ
- Laval, CA | view all locations
- Website
- http://www.bellushealth.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Ramzi Benamar, Chief Financial Officer
Denis Garceau, Chief Scientific Officer
Catherine Bonuccelli, Chief Medical Officer
Operating MetricsView all
Phase I Trials Products
1
Q2, 2019
Phase III Trials Products
1
Q2, 2019
LocationsView all
1 location detected
Laval, QC HQ
Canada
275 Boulevard Armand - Frappier
Bellus Health Financials
Summary Financials
- Revenue (Q1, 2023)
- $3.0K
- Gross profit (Q1, 2023)
- $3.0K
- Net income (Q1, 2023)
- ($25.1M)
- Cash (Q1, 2023)
- $8.6M
- EBIT (Q1, 2023)
- ($27.7M)